Full Text View
Tabular View
Study Results
Related Studies
An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))
This study has been completed.
Study NCT00568178   Information provided by Merck

First Received on December 3, 2007.   Last Updated on March 16, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Proteinuria
More general conditions related to this trial
Signs and Symptoms
Urination Disorders
Urologic Diseases
Urological Manifestations
Interventions listed in this trial
Losartan Potassium
Comparator: Placebo (Losartan)
Comparator: amlodipine besylate
Placebo (Losartan)
Enalapril Maleate
Additional drug interventions recognized in this trial
Amlodipine
Enalapril
Enalaprilat
Losartan
Maleic acid
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Anti-Arrhythmia Agents
Antihypertensive Agents
Calcium Channel Blockers
Cardiovascular Agents
Enzyme Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services